BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2025.
World J Stem Cells. Oct 26, 2025; 17(10): 109369
Published online Oct 26, 2025. doi: 10.4252/wjsc.v17.i10.109369
Figure 3
Figure 3 Expression levels of key genes in synovial fluid and cartilage tissue from osteoarthritis patients. A-D: Expression levels of GrpE-like 1 (A), epidermal growth factor-containing fibulin extracellular matrix protein 1 (B), serine protease inhibitor 5 (C), and Bcl2 interacting protein 3 Like (D) in synovial fluid from the normal and osteoarthritis groups, measured by quantitative real-time polymerase chain reaction; E-H: Expression levels of GrpE-like 1 (E), epidermal growth factor-containing fibulin extracellular matrix protein 1 (F), serine protease inhibitor 5 (G), and Bcl2 interacting protein 3 Like (H) in cartilage tissue from the normal and osteoarthritis groups, measured by quantitative real-time polymerase chain reaction. bP < 0.01. OA: Osteoarthritis; GRPEL1: GrpE-like 1; EFEMP1: Epidermal growth factor-containing fibulin extracellular matrix protein 1; SERPINA5: Serine protease inhibitor 5; BNIP3 L: Bcl2 interacting protein 3 like.


Write to the Help Desk